We serve 2-Acetyl-6-methoxynaphthalene CAS:3900-45-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 2-Acetyl-6-methoxynaphthalene
CAS.NO: 3900-45-6
Synonyms:
2-ACETYL-6-BROMONAPHTHALENE
6-Methoxy-2-acetyInaphthalene
2-ACETYL-METHOXY NAPHTHALENE
6'-Methoxy-2'-acetonaphthone
NAPROXEN IMP L
6-methoxy-2-acetyl-naphthalene
6-METHOXY-2-ACETONAPHTHONE
2-ACETYL-6-METHOXYNAPHTHALENE,CERTIFIED REFERENCE MATERIAL
1-(6-Methoxy-2-naphthalenyl)ethanone
6-Methoxy-2-acetyl
2-acetyl-6-methoxynapthalene
Molecular Formula: C13H12O2
Molecular Weight: 200.23300
Physical and Chemical Properties:
Density: 1.118 g / cm3
Boiling point: 155-160 ° C 0,4mm
Melting point: 107-109 ° C (lit.)
Flash point: 155-160 ° C / 0.4mm
Refractive index: 1.594
Specification:
Appearance:Light yellow-beige powder
Purity:≥99%
Water:0.5% max
Packing:
25kg cardboard drum or according to customer specified requirements
Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:
Intermediates of Naproxen sodium CAS: 26159-34-2
Contact us for information like 2-Acetyl-6-methoxynaphthalene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-acetyl-6-methoxynapthalene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-ACETYL-6-BROMONAPHTHALENE Use and application,2-ACETYL-6-BROMONAPHTHALENE technical grade,usp/ep/jp grade.
Related News: Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.Diethyl [(2-chloroethoxy)methyl]phosphonate manufacturer Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.1-bromo-2-(bromomethyl)benzene supplier Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.1,4,7,10-tetraazacyclododecane vendor Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.
